Markets
Organigram moves to buy Aurora for C$561M as Curaleaf keeps its hostile bid alive
A friendly all-Canadian deal at C$7.80 a share now competes with Curaleaf's amended hostile bid, and Aurora's board has picked a side.
M&A news
Every MetaFlora News story about M&A, newest first, with links to the original reporting.